CanSino’s performance/valuation is at low point, but MCV4's sales exceeded expectation.On 2023 low base, growth in 2024 is worth looking forward to.Potential catalyst for this winter cannot be ignored
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.